Practical Guidance for MedTech Reimbursement and Market Access
Insight on what matters most, and what it all means for your next milestone.
What Qualifies as DME? How Manufacturers Prove Durability
Learn Medicare's DME durability requirements and how manufacturers can build evidence to support DME classification and reimbursement. ...more
Payer Coverage
June 15, 2026•5 min read
PDAC Before CMS? What DME Companies Need to Know
Before pursuing a new HCPCS code, understand how PDAC evaluates your product and why coding strategy often begins before CMS. ...more
Coding and Payment
June 15, 2026•4 min read
What 2022-2025 CMS HCPCS Decisions Reveal About DME Reimbursement
Review four years of CMS HCPCS decisions and uncover 7 trends shaping coding, coverage, payment, and market access for DME technologies. ...more
Coding and Payment
June 15, 2026•8 min read
TPT and NT-APC: What MedTech Innovators Often Miss
TPT and NT-APC applications may look simple, but approval depends on understanding Medicare payment systems, pricing, coding, and adoption economics. ...more
Payer Coverage
June 15, 2026•5 min read
Inside the AMA CPT Process: Lessons for MedTech Founders
Learn what happens inside the AMA CPT process, why coding takes years, and how CPT decisions influence reimbursement, payment, and adoption. ...more
Coding and Payment
June 15, 2026•4 min read
Featured Insights for MedTech Innovators
Insights to help you validate your pathway, align with payer expectations, and move forward with confidence.
Clinical Trial Reimbursement in the U.S.: FAQs for MedTech Companies
A clear FAQ guide on how MedTech startups can secure Medicare reimbursement for clinical trials—and when it’s worth it. ...more
Coding and Payment ,Evidence Planning &Featured
March 19, 2025•4 min read
Beware Basing Your MedTech Pricing on Short-term New Tech Payment Mechanisms
New tech payments like NTAP can’t justify long-term pricing. Here’s what MedTech founders need to know. ...more
Coding and Payment ,Commercialization &Featured
March 04, 2025•3 min read
The Hidden Bias in Reimbursement: Why First Movers May Have It Easier
Why do better technologies struggle for reimbursement while outdated ones thrive? Discover the hidden bias in payer decision-making—and why second movers in MedTech face steeper evidence hurdles than ... ...more
Coding and Payment ,Evidence Planning Fundamentals &Featured
February 06, 2025•4 min read
The World After FDA Clearance: From HOORAY! To WAIT, WHAT?
FDA clearance is a milestone—not the finish line. Why reimbursement hurdles follow right after. ...more
Commercialization ,Fundamentals &Featured
August 20, 2024•5 min read
How Hospital Financial Decisions Shape the Fate of New MedTech Innovations
Hospitals are the gatekeepers of device adoption. Learn how to align with their economics. ...more
Commercialization ,Fundamentals &Featured
August 07, 2024•5 min read
Relearning English When it Comes to FDA and CMS Jargon
MedTech teams often misunderstand what regulators mean. This article translates FDA and CMS jargon into actionable insights for reimbursement. ...more
Fundamentals ,Featured
June 04, 2024•1 min read
Helping MedTech innovators achieve widespread reimbursement coverage in the U.S.
© 2026 Coustier Advisory LLC. All rights reserved.
Powered by Rocket Boost